✦ LIBER ✦

Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases

✍ Scribed by Nilsson, Sten; Franzén, Lars; Parker, Christopher; Tyrrell, Christopher; Blom, René; Tennvall, Jan; Lennernäs, Bo; Petersson, Ulf; Johannessen, Dag C.; Sokal, Michael; Pigott, Katharine; O'Bryan-Tear, Charles Gillies; Thuresson, Marcus; Bolstad, Bjørg; Bruland, Øyvind S.

Book ID: 123404539
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 394 KB
Volume: 11
Category: Article
ISSN: 1558-7673
DOI: 10.1016/j.clgc.2012.07.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Double-Blind, Dose-Finding

A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer

✍ Christopher C. Parker; Sarah Pascoe; Aleš Chodacki; Joe M. O'Sullivan; Josep R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 930 KB

A randomized, dose–response, multicenter

A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer

✍ S. Nilsson; P. Strang; A.K. Aksnes; L. Franzèn; P. Olivier; A. Pecking; J. Staff 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 512 KB

7018 Alpha-emitting Radium-223: two year

7018 Alpha-emitting Radium-223: two years follow up from a randomized phase II study in patients with bone metastases from hormone refractory prostate cancer

✍ Nilsson, S.; Franzen, L.; Parker, C.; Bolstad, B.; Ramdahl, T.; Thuresson, M.; B 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Overall Survival Benefit of Radium-223 C

Overall Survival Benefit of Radium-223 Chloride (Alpharadin™) in the Treatment of Patients with Symptomatic Bone Metastases in Castration-resistant Prostate Cancer (CRPC): a Phase III Randomized Trial (ALSYMPCA)

✍ C. Parker; D. Heinrich; J.M. O'Sullivan; S. Fossa; A. Chodacki; T. Demkow; A. Cr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

7011 A double-blind, randomised dose-res

7011 A double-blind, randomised dose-response phase II, multicentre study of radium-223 for the palliation of painful bone metastases in castration refractory prostate cancer patients

✍ Nilsson, S.; Strang, P.; Franzén, L.; Olivier, P.; Pecking, A.; Staffurth, J.; V 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Effect of radium-223 dichloride on sympt

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

✍ Sartor, Oliver; Coleman, Robert; Nilsson, Sten; Heinrich, Daniel; Helle, Svein I 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 527 KB